121 related articles for article (PubMed ID: 26298887)
1. [Immunotherapy for head and neck cancer].
Chikamatsu K
Gan To Kagaku Ryoho; 2015 Jul; 42(7):802-5. PubMed ID: 26298887
[No Abstract] [Full Text] [Related]
2. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
3. The fourth modality: immunotherapy for head and neck cancer hits pay dirt.
Bell RB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jun; 121(6):575-7. PubMed ID: 27181440
[No Abstract] [Full Text] [Related]
4. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
5. Immunotherapy for head and neck cancer.
Wu AA; Niparko KJ; Pai SI
J Biomed Sci; 2008 May; 15(3):275-89. PubMed ID: 18392689
[TBL] [Abstract][Full Text] [Related]
6. Viruses in head and neck cancers: prevention and therapy.
Psyrri A; Burtness B
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1365-71. PubMed ID: 18759688
[No Abstract] [Full Text] [Related]
7. [Immunocompetence and immunotherapy in patients with cancer of the head and neck region].
Vinzenz K; Micksche M
Z Stomatol; 1986 May; 83(3):203-18. PubMed ID: 3465128
[No Abstract] [Full Text] [Related]
8. Immune response to vaccination with DNA-Hsp65 in a phase I clinical trial with head and neck cancer patients.
Victora GD; Socorro-Silva A; Volsi EC; Abdallah K; Lima FD; Smith RB; Moyses RA; Zárate-Bladés CR; Michaluart P; Silva CL; Kalil J; Coelho V
Cancer Gene Ther; 2009 Jul; 16(7):598-608. PubMed ID: 19197326
[TBL] [Abstract][Full Text] [Related]
9. [Progress in head and neck cancer].
Ballivet de Régloix S; Dubray-Vautrin A; Girod A; Jouffroy T; Rodriguez J
Soins; 2015 Sep; (798):56; quiz 57. PubMed ID: 26369749
[No Abstract] [Full Text] [Related]
10. [The effect of immunotherapy and hyperthermia for advanced or recurrent head and neck cancer - 74 clinical cases].
Takeda T; Takeda H; Tanaka C; Maruhashi S; Takeda T
Gan To Kagaku Ryoho; 2014 Oct; 41(10):1283-5. PubMed ID: 25335718
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells and HNSCC: a potential treatment option? (Review).
Dunn G; Oliver KM; Loke D; Stafford ND; Greenman J
Oncol Rep; 2005 Jan; 13(1):3-10. PubMed ID: 15583794
[TBL] [Abstract][Full Text] [Related]
12. A dendritic cell based hybrid cell vaccine generated by electrofusion for immunotherapy strategies in HNSCC.
Weise JB; Maune S; Görögh T; Kabelitz D; Arnold N; Pfisterer J; Hilpert F; Heiser A
Auris Nasus Larynx; 2004 Jun; 31(2):149-53. PubMed ID: 15121224
[TBL] [Abstract][Full Text] [Related]
13. Increasing immunogenicity of cancer vaccines to improve their clinical outcome.
Parmiani G; Cimminiello C; Maccalli C
Expert Rev Vaccines; 2013 Oct; 12(10):1111-3. PubMed ID: 24124873
[No Abstract] [Full Text] [Related]
14. Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?
Ferris RL
ORL J Otorhinolaryngol Relat Spec; 2004; 66(6):332-40. PubMed ID: 15668533
[TBL] [Abstract][Full Text] [Related]
15. [Tumor biology, immunology, immunotherapy of head and neck carcinoma].
Z Stomatol; 1986 Apr; 83(2):185-93. PubMed ID: 3463106
[No Abstract] [Full Text] [Related]
16. Immune alterations and immunotherapy prospects in head and neck cancer.
Varilla V; Atienza J; Dasanu CA
Expert Opin Biol Ther; 2013 Sep; 13(9):1241-56. PubMed ID: 23789839
[TBL] [Abstract][Full Text] [Related]
17. [Immunotherapy of patients with head and neck carcinomas].
Tsukuda M
Gan To Kagaku Ryoho; 1996 Feb; 23(3):283-90. PubMed ID: 8712820
[TBL] [Abstract][Full Text] [Related]
18. Technology evaluation: Allovectin-7, Vical.
Galanis E
Curr Opin Mol Ther; 2002 Feb; 4(1):80-7. PubMed ID: 11883699
[TBL] [Abstract][Full Text] [Related]
19. Vaccination strategy to target lysyl oxidase-like 4 in dendritic cell based immunotherapy for head and neck cancer.
Weise JB; Csiszar K; Gottschlich S; Hoffmann M; Schmidt A; Weingartz U; Adamzik I; Heiser A; Kabelitz D; Ambrosch P; Görögh T
Int J Oncol; 2008 Feb; 32(2):317-22. PubMed ID: 18202753
[TBL] [Abstract][Full Text] [Related]
20. [Immunotherapy for head and neck squamous cell carcinoma].
Bron L; Romero P
Rev Med Suisse; 2006 Oct; 2(81):2216-9. PubMed ID: 17076151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
